Third Arc Bio raises $165M series A to develop biologics for cancer and immunology
The oversubscribed fundraising will enable Third Arc Bio to enter the clinic with multiple programs in 2025.
Archives for July 25, 2024
Biologics driving M&A as Agilent snaps up specialist BIOVECTRA for $925 million
As advanced therapies drive increasing market consolidation, the US giant Agilent Technologies has acquired the Canadian contract development and manufacturing organization (CDMO) BIOVECTRA for $925 million.
Suzanne LeBlang - passionate about patient care and the Focused Ultrasound Foundation
When she was young, Suzanne used to love hearing her father, a cardiologist, talking to his colleagues on the phone about patients and the care they needed.